1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Pfizer Global Medical Grants: Antimicrobial Stewardship and AMR is a competitive grant program from Pfizer Inc. that funds independent initiatives — including research, quality improvement, and education — aimed at improving patient outcomes in antimicrobial stewardship and combating antimicrobial resistance (AMR).
Pfizer publishes Requests for Proposals (RFPs) outlining specific gaps in research, practice, or care, and invites organizations to apply. Grantees are responsible for the design, implementation, and conduct of their initiatives. Eligible applicants include medical centers, universities, and healthcare organizations globally.
Awards typically range from $50,000 to $250,000. Applications are reviewed on a rolling RFP basis — check Pfizer's grants portal for current open solicitations.
Get alerted about grants like this
Get emailed when new opportunities from “Pfizer Inc.” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Competitive Grants Program | Pfizer Clinical Trials in Children Integrity and Transparency Plain Language Study Results Expanded Access & Compassionate Use Inflammation & Immunology PfizerPro for Professionals Patient Assistance Programs Behind the Science Features Patient Advocacy & Engagement Diversity, Equity, and Inclusion Environmental Sustainability Stem Cell Research Policy Working with Healthcare Professionals Prescription Value & Pricing Corporate Governance Overview Board Committees & Charters The Pfizer Board Policies Corporate Governance FAQs Research and Business Development Partnerships Submit Your Opportunities Suggestions within Pfizer.
com Competitive Grants Program Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.
The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Independent Medical Education Investigator Sponsored Research Inflammation & Immunology Support for the Professions British Indian Ocean Territory Congo, The Democratic Republic Falkland Islands (Malvinas) French Southern Territories Heard and Mc Donald Islands Holy See (Vatican City State) Iran (Islamic Republic of) Korea, Democratic People's Rep Lao People's Democratic Republ Macedonia, The Former Yugoslav Micronesia, Federated States o Saint Vincent and the Grenadin Slovakia (Slovak Republic) South Georgia and the South Sa Svalbard and Jan Mayen Islands Tanzania, United Republic of United States Minor Outlying I Wallis and Futuna Islands Shared Decision Making in Hemophilia Patient Care Release Date: December 11, 2025 Review Process: Pfizer Internal View RFP (PDF) Quality Improvement Rare Disease China March 12, 2026 Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC) Release Date: January 8, 2026 Review Process: Expert Review Panel View RFP (PDF) Quality Improvement Oncology Canada March 17, 2026 Optimizing HRRm Testing and Workflow Integration in mCSPC Release Date: January 12, 2026 Review Process: Expert Review Panel View RFP (PDF) Quality Improvement, Research Oncology Canada April 8, 2026 Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in China Release Date: January 15, 2026 Review Process: Pfizer Internal View RFP (PDF) Research Inflammation & Immunology China March 31, 2026 Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource Utilizatio Release Date: January 15, 2026 Review Process: Pfizer Internal View RFP (PDF) Research Inflammation & Immunology China March 31, 2026 Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across Canada Release Date: January 15, 2026 Partner: Colorectal Cancer Canada (CCC) Review Process: Expert Review Panel View RFP (PDF) Quality Improvement, Research Oncology Canada April 15, 2026 Optimizing Disease Management to Improve Alopecia Areata Quality of Care Release Date: January 15, 2026 Review Process: Pfizer Internal View RFP (PDF) Quality Improvement Inflammation & Immunology China April 30, 2026 Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for Vitiligo Release Date: January 16, 2026 Review Process: Pfizer Internal View RFP (PDF) Research Inflammation & Immunology China March 19, 2026 Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC) Release Date: January 26, 2026 Partner: American Society for Clinical Pathology (ASCP) Review Process: Expert Review Panel View RFP (PDF) Quality Improvement Oncology USA March 31, 2026 Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factors Release Date: January 26, 2026 Review Process: Expert Review Panel View RFP (PDF) Quality Improvement, Research Oncology Italy March 27, 2026 Inflammation & Immunology Support for the Professions British Indian Ocean Territory Congo, The Democratic Republic Falkland Islands (Malvinas) French Southern Territories Heard and Mc Donald Islands Holy See (Vatican City State) Iran (Islamic Republic of) Korea, Democratic People's Rep Lao People's Democratic Republ Macedonia, The Former Yugoslav Micronesia, Federated States o Saint Vincent and the Grenadin Slovakia (Slovak Republic) South Georgia and the South Sa Svalbard and Jan Mayen Islands Tanzania, United Republic of United States Minor Outlying I Wallis and Futuna Islands Pneumococcal Disease Prevention Release Date: April 11, 2012 Review Process: View RFP (PDF) Release Date: May 8, 2012 Review Process: View RFP (PDF) Release Date: June 28, 2012 Review Process: View RFP (PDF) Pharmacy Pneumococcal Disease Prevention Release Date: June 28, 2012 Review Process: View RFP (PDF) Release Date: July 2, 2012 Review Process: View RFP (PDF) Non-Small Cell Lung Cancer Release Date: July 10, 2012 Review Process: View RFP (PDF) Cardiovascular Risk in Rheumatoid Arthritis Release Date: July 25, 2012 Review Process: View RFP (PDF) Release Date: July 26, 2012 Review Process: View RFP (PDF) Adult Pneumococcal Disease Prevention Release Date: August 29, 2012 Review Process: View RFP (PDF) Prevention of Stroke in Women Release Date: September 13, 2012 Review Process: View RFP (PDF) Oncology Educational Needs Assessments Release Date: October 22, 2012 Review Process: View RFP (PDF) Release Date: November 1, 2012 Review Process: View RFP (PDF) This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.
According to the current listing, eligibility includes: Medical centers, universities, and healthcare organizations. Confirm the full requirements in the official notice before applying.
The current listing shows $50,000 - $250,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Pfizer Global Medical Grants: Antimicrobial Stewardship and AMR is funded by Pfizer Inc.. Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism is sponsored by Pfizer Inc. and Bristol-Myers Squibb (BMS). This funding opportunity supports continuing professional education in the areas of anticoagulation in atrial fibrillation and venous thromboembolism. It aims to support innovative, independent medical education for healthcare professionals.
Competitive Grants Program (General RFP for independent initiatives) is a grant from Pfizer Inc. that funds arts projects and programming. Project Types and Area of Interest Potential applicants are encouraged to identify and address educational gaps relating to optimal application and management of targeted therapies for patients with mPC in diverse clinical practice settings. Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society). Eligible applicants include medical, scientific, patient, and civic organizations; healthcare institutions; professional associations; medical societies; medical education companies; and other healthcare-related entities.
Brown Girl Jane x SheaMoisture Grant is a grant from SheaMoisture and Brown Girl Jane that funds Black and woman-owned beauty and wellness businesses in the United States. Part of SheaMoisture's broader commitment to addressing racial inequality through its $1 million annual giving fund, this program specifically supports founders at the intersection of Black and women-owned entrepreneurship in the beauty and wellness sector. Applicants must be based in the U.S. and have operated their business for at least one year. Grants range from $10,000 to $25,000. Check the SheaMoisture Fund website for the current open cycle, as deadlines vary by cohort.
Support Adoption Grant Program is sponsored by Texas Office of the Attorney General. This program provides critical resources for pregnant women considering adoption and support for children awaiting placement with adoptive parents. Purpose areas include material needs for pregnant women, needs of children awaiting placement, training and advertising related to adoption, and pre- and post-adoption counseling.